Observational Study to Assess the Effect of Iluvien® in DME Patients Insufficiently Responsive to Available Therapies

Rapid Structural and Functional Improvements in Following 0.19 mg Fluocinolone Acetonide (FAc) Implant in Diabetic Macular Edema Patients With Poor Visual Acuity: 12-month Audit Results From United Arab Emirates

NCT03590587 ·Status: UNKNOWN

Post Marketing Study to Evaluate the Safety and Effectiveness of Brolucizumab in Patients With Diabetic Macular Edema.

NCT05959304 ·Status: COMPLETED ·Phase: PHASE4

Medico Economic Evaluation of Fluocinolone Acetonide Implant Versus Dexametheasone Implant in Resistant Diabetic Macular Oedema

NCT04910503 ·Status: RECRUITING ·Phase: PHASE4

Safety and Efficacy of Intravitreal Fluocinolone Acetonide Implants in Patients With Diabetic Macular Edema

NCT00576459 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of Topical Administration of FOV2304 (High Dose or Low Dose) for the Treatment of Center-involving Clinically Significant Macular Edema Associated With Diabetic Retinopathy

NCT01319487 ·Status: COMPLETED ·Phase: PHASE2

Topical Ocular Mecamylamine in Diabetic Macular Edema (DME)

NCT00536692 ·Status: COMPLETED ·Phase: PHASE2

Routine Clinical Practice for Use of Intravitreal Aflibercept Treatment in Patients With Diabetic Macular Edema

NCT02924311 ·Status: COMPLETED

Efficacy of Fluocinolone Acetonide Intravitreal Implant in Diabetic Macular Edema

NCT00502541 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Diabetic Macular Edema: Relevance of Staging Progression on Therapeutic Outcome

NCT05080803 ·Status: COMPLETED

Efficacy and Safety of Aflibercept as Mono-therapy in Treat and Extend Regimen for DME Patients in Taiwan

NCT04288232 ·Status: COMPLETED ·Phase: PHASE3

Comparative Study of Dexamethasone Implant to Intravitreal Aflibercept in Subjects With Diabetic Macular Edema

NCT04411693 ·Status: COMPLETED ·Phase: PHASE4

Treatment of Diabetic Macular Edema (DME) With Anti-VEGF and Focal Laser

NCT03590444 ·Status: COMPLETED ·Phase: PHASE4

Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema

NCT03927690 ·Status: COMPLETED ·Phase: PHASE2

Investigation of the Change of Vision-related Quality of Life in Subjects Treated With Aflibercept According to EU Label for DME.

NCT02581995 ·Status: COMPLETED ·Phase: PHASE4

Intravitreal Aflibercept Injection in Vision Impairment Due to DME

NCT01331681 ·Status: COMPLETED ·Phase: PHASE3

Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Diabetic Macular Edema

NCT00959725 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Identifying Patients With Unrecognized Treatable Diabetic Macular Edema

NCT01934920 ·Status: UNKNOWN

Intravitreal Dexamethasone Implant for Refractory Diabetic Macular Edema:

NCT05847088 ·Status: COMPLETED

Safety and Effect on Central Retinal Thickness of BI 1026706 in Patients With Diabetic Macular Edema

NCT02732951 ·Status: COMPLETED ·Phase: PHASE2

A Dose Escalation Study of IBI324 in Subjects With Diabetic Macular Edema

NCT05489718 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Efficacy and Safety of IBI302 inSubjects With Diabetic Macular Edema（DME）

NCT06908876 ·Status: RECRUITING ·Phase: PHASE2

A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema

NCT06962839 ·Status: RECRUITING ·Phase: PHASE2

Anti-VEGF Therapy Versus Dexamethasone Implant for DME

NCT03999125 ·Status: UNKNOWN ·Phase: PHASE4

A Study to Learn How Safe the Study Drug Intravitreal (Given by an Injection Into the Eye) Aflibercept is in Participants in India With Diabetic Macular Edema

NCT05511038 ·Status: COMPLETED ·Phase: PHASE4

Utility of Intravitreal Methotrexate in Diabetic Macular Edema Resistant to Conventional Therapies

NCT00779142 ·Status: TERMINATED ·Phase: NA